Variant report
Variant | esv1816195 |
---|---|
Chromosome Location | chr8:52029240-52031261 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10100485 | chr8:52029240-52029241 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs538588586 | chr8:52029255-52029256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557296087 | chr8:52029318-52029319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569145641 | chr8:52029358-52029359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536468355 | chr8:52029364-52029365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140030084 | chr8:52029387-52029388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572973823 | chr8:52029388-52029389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572176838 | chr8:52029397-52029398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530648490 | chr8:52029403-52029404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10090890 | chr8:52029420-52029421 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs551928772 | chr8:52029431-52029432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368484394 | chr8:52029458-52029459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371350358 | chr8:52029492-52029493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1869757 | chr8:52029567-52029568 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs531143869 | chr8:52029615-52029616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74846552 | chr8:52029657-52029658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs28460246 | chr8:52029666-52029667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1869756 | chr8:52029669-52029670 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs528674994 | chr8:52029692-52029693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12544225 | chr8:52029738-52029739 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs184657768 | chr8:52029742-52029743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570224933 | chr8:52029754-52029755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563292390 | chr8:52029755-52029756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12549225 | chr8:52029775-52029776 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs371615440 | chr8:52029820-52029821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189447557 | chr8:52029823-52029824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12541840 | chr8:52029844-52029845 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs147570154 | chr8:52029886-52029887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12549244 | chr8:52029916-52029917 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs113874397 | chr8:52029924-52029925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528132580 | chr8:52029939-52029940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs180833210 | chr8:52029950-52029951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545082622 | chr8:52029951-52029952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144168157 | chr8:52029970-52029971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575229172 | chr8:52029982-52029983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372111465 | chr8:52030043-52030044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28625320 | chr8:52030069-52030070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs561587588 | chr8:52030076-52030077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546279081 | chr8:52030151-52030152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571502617 | chr8:52030155-52030156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540792525 | chr8:52030170-52030171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564845843 | chr8:52030174-52030175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35482560 | chr8:52030179-52030180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28612111 | chr8:52030181-52030182 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs550677033 | chr8:52030183-52030184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28499187 | chr8:52030184-52030185 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs67401108 | chr8:52030231-52030232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184910560 | chr8:52030238-52030239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376417791 | chr8:52030243-52030244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs67449945 | chr8:52030255-52030256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52028200-52029400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:52029200-52030200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr8:52030200-52035000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |